260 participants
A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-22
- Start Date:
- 2022-09-23
- Completion:
- 2026-01-28
Conditions
- Solid Tumors
Interventions
- DRUG
No Results Yet